美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant

0.3100

-0.1850-37.37%

成交量：9,036.00

成交额：3,820.88

市值：882.53万

市盈率：-0.01

高：0.5528

开：0.5367

低：0.3100

收：0.4950

52周最高：0.8121

52周最低：0.0525

股本：2,846.86万

流通股本：2,846.86万

量比：2.07

换手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-20.7379

净资产收益率：-301.83%

总资产收益率：-75.63%

市净率：1.21

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

bioAffinity Technologies启动其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究

bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究，拓展Cypath® Lung无创肺癌早筛检测的样本采集选项

bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法

bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资，定价符合纳斯达克市场规则

bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BIAFW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIAFW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","market":"US","secType":"STK","nameCN":"bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant","latestPrice":0.31,"timestamp":1773864000000,"preClose":0.495,"halted":0,"volume":9036,"delay":0,"changeRate":-0.37373737373737376,"floatShares":28468614,"shares":28468614,"eps":-20.7379,"marketStatus":"盘后交易","change":-0.185,"latestTime":"03-18 16:50:12 EDT","open":0.5367,"high":0.5528,"low":0.31,"amount":3820.87957,"amplitude":0.490505,"askPrice":0.35,"askSize":3229,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.7379,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":4,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.495,"volumeRatio":2.073809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","floatShares":28468614,"roa":"-75.63%","roe":"-301.83%","lyrEps":0,"volumeRatio":2.073809,"shares":28468614,"dividePrice":0,"high":0.5528,"amplitude":0.490505,"preClose":0.495,"low":0.31,"week52Low":0.0525,"pbRate":"1.21","psRate":"1.43","week52High":0.8121,"institutionHeld":0,"latestPrice":0.31,"committee":-1,"eps":-20.7379,"divideRate":0,"volume":9036,"delay":0,"ttmEps":-20.7379,"open":0.5367,"prevYearClose":0.35,"prevWeekClose":0.3299,"prevMonthClose":0.28,"prevQuarterClose":0.35,"fiveDayClose":0.3343,"twentyDayClose":0.2204,"sixtyDayClose":0.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIAFW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"BIAFW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIAFW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIAFW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIAFW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158495268","title":"bioAffinity Technologies启动其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1158495268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158495268?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 19:49","pubTimestamp":1773143344,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies公司宣布，已启动一项针对其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究。该研究旨在通过长期跟踪和数据收集，进一步验证该诊断方法的有效性与可靠性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"1186193545","title":"bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究，拓展Cypath® Lung无创肺癌早筛检测的样本采集选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1186193545","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186193545?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 21:32","pubTimestamp":1772026320,"startTime":"0","endTime":"0","summary":"生物亲和技术公司（bioAffinity Technologies）宣布，将与布鲁克陆军医疗中心（Brooke Army Medical Center）合作开展一项验证研究，旨在扩大其Cypath® Lung无创早期肺癌检测技术的样本采集方式。此项研究将评估不同样本采集方案的有效性，以提升该检测技术的可及性和应用便利性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BIAFW","BK4139"],"gpt_icon":0},{"id":"1142229976","title":"bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229976","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229976?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 20:01","pubTimestamp":1760616074,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"1129857267","title":"bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资，定价符合纳斯达克市场规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1129857267","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129857267?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 03:47","pubTimestamp":1759952838,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资，本次融资通过发行普通股实现，股票定价按照纳斯达克市场规则执行。\n此次融资采用按市价定价的方式进行，严格遵循纳斯达克交易所的相关规定和要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF","BIAFW"],"gpt_icon":0},{"id":"1116292885","title":"bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1116292885","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116292885?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 20:16","pubTimestamp":1758111399,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}